Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Tectonic Therapeutic (TECX) Interest Expenses (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Interest Expenses data on record, last reported at $8000.0 in Q1 2026.

  • On a quarterly basis, Interest Expenses fell 60.0% to $8000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $51000.0, a 46.32% decrease, with the full-year FY2025 number at $63000.0, down 41.12% from a year prior.
  • Interest Expenses reached $8000.0 in Q1 2026 per TECX's latest filing, down from $12000.0 in the prior quarter.
  • Over the last five years, Interest Expenses for TECX hit a ceiling of $45000.0 in Q1 2022 and a floor of $8000.0 in Q1 2026.
  • A 5-year average of $25538.5 and a median of $25000.0 in 2024 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: skyrocketed 80.0% in 2022, then crashed 60.0% in 2026.
  • Tracing TECX's Interest Expenses over 5 years: stood at $45000.0 in 2022, then decreased by 24.44% to $34000.0 in 2023, then crashed by 35.29% to $22000.0 in 2024, then tumbled by 45.45% to $12000.0 in 2025, then tumbled by 33.33% to $8000.0 in 2026.
  • Business Quant data shows Interest Expenses for TECX at $8000.0 in Q1 2026, $12000.0 in Q4 2025, and $14000.0 in Q3 2025.